Cervical Cancer Detection Using Optical Spectroscopy

Duke University350 enrolled

Overview

The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

350

Conditions

Cervical Cancer

Interventions

Optical Spectroscopy Bench-Top SystemDEVICE

This device is a bench-top optical spectrometer

Portable Optical SpectrometerDEVICE

This device is a portable optical spectrometer

Transvaginal colposcopeDEVICE

Eligibility

Sex: FEMALEMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * undergoing colposcopy for the diagnosis of cervical cancer * LEEP for the treatment of cervical cancer in early stages. * Follow-up Pap smear in surveillance Exclusion Criteria: * Women under the age of 18 (minors) will be excluded from this study. * patients will be excluded if she has had a recent episode of bleeding or preterm labor. * Subjects who are not competent to give consent will excluded

Locations (1)

Duke University Medical Center

Durham, North Carolina, United States

RECRUITING

Outcomes

Primary Outcomes

Identification of optical signatures of cervical tissue

The primary outcome of this study is the identification of the optical signatures of cervical tissue.

Time frame: Day of procedure (less than 10 minutes)

Central Contacts

Nimmi Ramanujam, Ph.D.

CONTACT

919-660-5307 nimmi@duke.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.